×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
MAXIMISING THE VALUE OF POST-APPROVAL STUDIES THROUGH PUBLICATION EXCELLENCE
Session Chair(s)
Jens Reinhold, MD
Head Medical Affairs EMEA
Bayer Pharma AG, Germany
Learning Objective : 1. Which project related documents and publication types should be used in late-phase research? 2. What are the specific needs in a team required for successful communication of late-phase research? 3. What can be done to focus on your publications on your key topics and audiences? 4. What can be done to combine a coordinated communication approach with local expertise?
Speaker(s)
Integrated Publication-Planning in Late-Phase Research
Thomas Wagner
Trilogy Writing & Consulting, Germany
Medical Writing Manager
Maximising the Value of Post-Approval Studies
Nancy J Vobecky, MS
Bayer Healthcare Pharmaceuticals Inc., United States
Head, Publications and Communications - Global Medical Affairs Oncology
Have an account?